Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Steroids, particularly estrogens and 5α-reductase inhibitors, affect blood vessel-related hair growth processes in hair follicle cells.

Women generally handle heart enlargement better than men, but it's riskier for them if it occurs; hormones like estrogen offer some protection.

Melatonin helped some Pomeranian dogs regrow hair, but it wasn't linked to estrogen receptors.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

Estrogen increases blood vessel growth factor production, while testosterone blocks this increase.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Estrogen and prolactin may play bigger roles in female hair loss than previously thought.

Low estrogen compared to androgen may cause female hair loss.

Adding estrogen increased bone mass in a transsexual man undergoing hormone therapy.

The medication combination did not affect glucose tolerance but increased some cholesterol levels due to its estrogen component.

Estrogen deficiency, like after menopause or certain surgeries, leads to faster skin aging and health issues.

Estrogen receptors may not affect mouse hair growth as previously thought, and oxybenzone in sunscreen is stable in sunlight.

Hormones during puberty increase certain receptors in the brain, and this change is influenced by estrogen levels.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Transgender women on estrogen therapy can develop melasma and need proper skin care.

Men born very underweight had higher estrogen levels but normal reproduction compared to normal birth weight men.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

Birth control pills with low-dose estrogen and antiandrogenic progestins can effectively treat acne.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Cyproterone acetate is a safe treatment that causes modest feminization in transgender female adolescents, and works better with added estrogens.

Young women in West Bengal, India, with PCOS often have estrogen resistance, leptin receptor issues, folate deficiency, T2DM, and acanthosis, commonly linked to obesity.

Dihydrotestosterone makes arteries stiffer in female mice by reducing estrogen receptor expression.

The paper suggests that a decrease in estrogen receptor activity may cause sexual dysfunction syndromes and proposes hormonal treatments.

Estrogens and progesterone are key in regulating melasma pigmentation.

Transgender females can reach their target estrogen levels using estradiol patches, especially if oral treatments fail or if they're at risk for blood clots. Often, the highest dose patch is needed.

Androgens and estrogens are crucial for insulin secretion in males.

Cancer rates are increasing in developed countries, with estrogen, aging, low vitamin D3, and HPV infection as common causes.

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.